Advertisement

FDA Approves Novel Implantable Device for Sleep Apnea — Physician’s First Watch

Medical News |
May 2, 2014

FDA Approves Novel Implantable Device for Sleep Apnea

By Kristin J. Kelley

The FDA has approved a new treatment — Inspire Upper Airway Stimulation therapy — for patients with moderate-to-severe obstructive sleep apnea who cannot use a continuous positive airway pressure machine.

The device is implanted in the upper chest, senses breathing patterns, and mildly stimulates the airway muscles, keeping the airway open. The device is turned on and off using a handheld remote.

In a study published in the New England Journal of Medicine, some 125 patients (83% men, mean age: 55 years) had the device implanted. At 12 months, the number of apnea events per hour decreased by 68% and oxygen desaturation events decreased by 70%.

The procedure to implant the device has a shorter recovery time than surgery to alter airway or facial anatomy, according to the manufacturer. It is expected to be available to patients by the end of 2014.

Reader Comments (1)

Ricardo Benzadón MD Physician, Hematology, CEMIC University Hospital

Journal Watch keep me updated in all fields. I very much apreciate this. Thank you!

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement